Client Result
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. to Combine to Form Dogwood Therapeutics, Inc.
2 minute read | October.07.2024

2 minute read | October.07.2024
2 minute read | April.10.2024
Onconova Therapeutics and Trawsfynydd Therapeutics have entered into a definitive merger agreement to combine to form Traws Pharma.
2 minute read | August.28.2023
Ferring Pharmaceuticals and Royalty Pharma have entered into a royalty agreement for sales of Ferring’s new gene therapy for bladder cancer.
June.27.2022
The primary focus of the acquisition is on the lead medicine, Tazverik® (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor.
January.21.2022
December.17.2021